2nd Quarter - Report

ADVANCED STRATEGIES for COVIDIEN, INC.

Firm
Client
Income
$110,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

S. 232 Medical Device Access & Innovation Protection Act H.R. 523 Protection of Medical innovation International Tax Issues

LobbyistCovered position, as disclosed
JOHN SASSO N.A.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 523 (113th), S. 232 (113th)

Health Issues HCR

Food and Drug Administration Processes

LobbyistCovered position, as disclosed
JOHN SASSO N.A.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.